7.65
1.29%
-0.10
Dopo l'orario di chiusura:
7.68
0.03
+0.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IBRX Giù?
Forum
Previsione
ImmunityBio Inc Azioni (IBRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
69.51%
0.139
|
0.082 | 0.041 | 0.36 | 0.073 |
Operating Expenses
|
6.62%
85.53
|
80.22 | 85.19 | 111.94 | 84.97 |
Interest Income/Expense |
8.27%
32.13
|
35.02 | 32.23 | 29.82 | 28.56 |
Benefits Costs and Expenses |
144.03%
233.59
|
95.72 | 138.25 | 116.94 | 108.36 |
Costs And Expenses |
144.03%
233.59
|
95.72 | 138.25 | 116.94 | 108.36 |
Operating Income/Loss |
6.56%
-85.39
|
-80.14 | -85.14 | -111.58 | -84.90 |
Nonoperating Income/Loss |
854.89%
-148.06
|
-15.51 | -53.07 | -5.003 | -23.39 |
Income/Loss Before Equity Method Investments |
147.34%
-233.45
|
-94.39 | -134.26 | -114.25 | -104.74 |
Income/Loss From Equity Method Investments |
100.00%
-
|
-1.255 | -3.957 | -2.337 | -3.554 |
Income/Loss From Continuing Operations Before Tax |
144.09%
-233.45
|
-95.64 | -138.21 | -116.58 | -108.29 |
Income Tax Expense/Benefit |
-0.04
|
- | - | - | 0.034 |
Income/Loss From Continuing Operations After Tax |
144.05%
-233.41
|
-95.64 | -138.21 | -116.58 | -108.33 |
Net Income/Loss
|
144.05%
-233.41
|
-95.64 | -138.21 | -116.58 | -108.33 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
63.33%
-0.022
|
-0.06 | -0.334 | -0.24 | -0.111 |
Basic Average Shares |
89.24%
53.64
|
498.38 | 437.46 | 428.38 | 1.2478 |
Diluted Average Shares |
89.24%
53.64
|
498.38 | 437.46 | 428.38 | 1.2478 |
Basic Earnings Per Share |
100.00%
-0.38
|
-0.19 | -0.32 | -0.27 | -0.27 |
Diluted Earnings Per Share |
100.00%
-0.38
|
-0.19 | -0.32 | -0.27 | -0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):